MedPath

Pre-procedural 3DCT Versus Angiography Guided PCI for Ostial Right Coronary Artery Lesions

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Other: Angiography guided PCI
Device: 3DCT-scan
Registration Number
NCT05172323
Lead Sponsor
Ziekenhuis Oost-Limburg
Brief Summary

Even with second generation drug eluting stents, rates of target lesion failure (TLF) for aorto-ostial RCA lesions remain high \[3yrs TLF 14.2%\]. Retrospective studies show that stent underexpansion and geographical stent-ostium mismatch are the main predictors for TLF. Geographical mismatch means that the stent is implanted either too distal (thereby not fully covering the lesion) or too proximal (thereby protruding too much in the aorta and hampering future engagement with guiding catheters). The investigators hypothesize that, pre-procedural 3D CT coronarography to determine the optimal C-arm angle of the X-ray system with the most accurate visualization of the aorto-ostial angle and determination of localization of calcium, could prevent geographical mismatch.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Clinically indicated non-emergent PCI for an aorta-ostial-RCA lesion defined as a significant de novo lesion [by angiography or by physiological assessment] for which the operator intends to fully cover the ostial RCA with stent struts
  • Willing to provide informed consent
Exclusion Criteria
  • Emergent PCI indication: if the ostial RCA lesion is the culprit lesion of an acute coronary syndrome [of note: if the ostial RCA lesion is a non-culprit lesion, patient can be included in the trial]
  • In-stent restenosis or thrombosis in the ostial RCA
  • Renal insufficiency [eGFR<30 ml/min]
  • Known allergic reaction to contrast medium

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Angiography-guided groupAngiography guided PCIPCI guided by operator and IVUS
3DCT-guided group3DCT-scanPCI guided with 3DCT results and IVUS
Primary Outcome Measures
NameTimeMethod
Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)Procedural

Distance between the aorta-ostial junction and the most proximal protruding stent strut (in mm).

Secondary Outcome Measures
NameTimeMethod
Procedural radiation doseProcedural

Expressed in mGy

Volume of contrast agent administeredProcedural

Expressed in mL

Minimal luminal area (MLA)Procedural

The predicted MLA by 3DCT will be compared with the MLA prior to stent placement as obtained with IVUS

Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)Procedural

The percentage of patients who need an additional stent after the final IVUS has shown that the ostium was not fully covered

Calcified lesionsProcedural

Calcium score as determined by 3DCT will be correlated with the maximum calcium arc on IVUS

Procedural duration from first puncture of artery to skin closureProcedural

Expressed in minutes

Stent expansionProcedural

Expressed as the minimal stent area (MSA) determined by IVUS, divided by the reference luminal area in the healthy distal landing zone

Stent sizingProcedural

Predicted stent diameter and length by 3DCT will be compared with the effectively implanted stent size

Calcium modificationProcedural

Prediction of calcium modification pre-IVUS compared with IVUS based strategy of calcium modification

MACCE at 30 days follow-up30 days after PCI

30 days event rate \[death, non-fatal MI, non-fatal stroke, definite or probable stent thrombosis, target lesion failure\]

Trial Locations

Locations (1)

Ziekenhuis Oost-Limburg

🇧🇪

Genk, Limburg, Belgium

© Copyright 2025. All Rights Reserved by MedPath